Sandro Nuciforo
10PUBLICATIONS
75CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Aug 25, 2025
The HDAC inhibitor romidepsin renders liver cancer vulnerable to RTK targeting and immunologically active.Celia Sequera, Margherita Grattarola, Floriane Cannet
|Feb 19, 2025
Human-correlated genetic models identify precision therapy for liver cancer.Miryam Müller, Stephanie May, Holly Hall
|May 02, 2024
Inhibition of the transmembrane transporter ABCB1 overcomes resistance to doxorubicin in patient-derived organoid models of HCC.Lauriane Blukacz, Sandro Nuciforo, Geoffrey Fucile
|Nov 03, 2023
Patient-derived organoids identify tailored therapeutic options and determinants of plasticity in sarcomatoid urothelial bladder cancer.Michele Garioni, Viviane J Tschan, Lauriane Blukacz
|Jul 05, 2022
Patient-derived tumor organoids for personalized medicine in a patient with rare hepatocellular carcinoma with neuroendocrine differentiation: a case report.Marie-Anne Meier, Sandro Nuciforo, Mairene Coto-Llerena
|May 04, 2022
Integrative proteogenomic characterization of hepatocellular carcinoma across etiologies and stages.Charlotte K Y Ng, Eva Dazert, Tuyana Boldanova
Pageof 2
Frequent Collaborators
8 joint publications
Markus H Heim
5 joint publications
Salvatore Piscuoglio
4 joint publications
Charlotte K Y Ng
3 joint publications
Caner Ercan
3 joint publications
Lauriane Blukacz
3 joint publications
Mairene Coto-Llerena
2 joint publications
Eva Dazert
2 joint publications
Thomas Bock
2 joint publications
Matthias S Matter
2 joint publications
John Gallon
